Latest Form 4 insider transactions
NYSE
GATX
Gatx CORPGeoffrey Phillips, Sr. VP, Operations of Gatx Corp, reported a transaction in 70 shares of common stock on August 15, 2026.
NASDAQ
TRIP
Tripadvisor, INCAlmir Ambeskovic, CEO, TheFork of TripAdvisor, Inc., reported multiple transactions in common stock on August 14, 2026.
NASDAQ
FSBW
Fs Bancorp, INCSean Mccormick, Chief Credit Administration of FS Bancorp, Inc., reported multiple transactions in common stock on August 14, 2026.
NASDAQ
Manher Joshi, Chief Medical Officer of Rhythm Pharmaceuticals, Inc., reported multiple transactions in common stock on August 17, 2026.
NYSE
Form 4: Sweetgreen CFO Sells Shares
Jamie Mcconnell, Chief Financial Officer of Sweetgreen, Inc., sold 15,033 shares of common stock on August 17, 2026 for $6.21 per share.
NASDAQ
TRIP
Tripadvisor, INCGeoffrey Gouvalaris, Chief Accounting Officer of TripAdvisor, Inc., reported multiple transactions in common stock on August 14, 2026.
NASDAQ
Radhika Tripuraneni, Chief Medical Officer of Viridian Therapeutics, Inc.\DE, reported multiple transactions in common stock on August 14, 2026.
NYSE
Jamie Mcconnell, Chief Financial Officer of Sweetgreen, Inc., sold 1,401 shares of common stock on May 18, 2026 for $8.00 per share.
NASDAQ
TRIP
Tripadvisor, INCKristen Ann Dalton, Chief Strategy & Ops Officer of TripAdvisor, Inc., reported multiple transactions in common stock on August 14, 2026.
NASDAQ
Kelly Brady, See Remarks of Seres Therapeutics, Inc., sold 64 shares of common stock on August 15, 2026 for $4.55 per share.
NYSE
Lisa R Bacus, a Director of Teradata Corp /De/, received 2,197 shares of common stock on August 14, 2026.
NASDAQ
Laura Kathleen Bartels, Chief Accounting Officer of Arm Holdings Plc /Uk, reported multiple transactions in common stock on August 17, 2026.
NYSE
MPLX
Mplx LpGarry L. Peiffer, a Director of Mplx Lp, received 1,232 shares of common stock on August 14, 2026.
NYSE
Carl Douglas Anderson Ii, SVP and CFO of Axalta Coating Systems Ltd., reported multiple transactions in common stock on August 14, 2026.
NASDAQ
Ryan Michael Boland, a Director of Firefly Aerospace Inc., reported multiple transactions in common stock on August 14, 2026.
NYSE
Melissa B Fisher, a Director of Teradata Corp /De/, received 2,197 shares of common stock on August 14, 2026.
NASDAQ
WATT
Energous CORPRahul G. Patel, a Director of Energous Corp, received 3,021 shares of common stock on August 17, 2026.
NASDAQ
WATT
Energous CORPJ Michael Dodson, a Director of Energous Corp, received 2,938 shares of common stock on August 17, 2026.
NASDAQ
WATT
Energous CORPDavid Earle Roberson, a Director of Energous Corp, received 8,050 shares of common stock on August 17, 2026.
NASDAQ
CPRT
Copart INCForm 4: Copart CFO Receives Stock Grant
Leah C Stearns, Chief Financial Officer of Copart Inc, reported multiple transactions in common stock on August 16, 2026.
OQX
Virginia R Summerell, a Director of Guerrilla RF, Inc., received 14,164 shares of common stock on August 14, 2026.
NYSE
Form 4: Sweetgreen COO Sells Shares
Jason Miles Cochran, Chief Operating Officer of Sweetgreen, Inc., sold 4,809 shares of common stock on August 17, 2026 for $6.21 per share.
NYSE
John Taylor Maloney Fitzgerald, President and CEO and a Director of Kingsway Financial Services Inc, purchased 254 shares of common stock on August 17, 2026 for $9.87 per share.
NASDAQ
Tracy Ann Feanny, SVP, General Counsel of Lattice Semiconductor Corp, reported multiple transactions in common stock on August 16, 2026.
NASDAQ
Eric D. Shaff, a Director of Seres Therapeutics, Inc., sold 263 shares of common stock on August 15, 2026 for $4.55 per share.
NASDAQ
CDLX
Cardlytics, INCForm 4: Cardlytics CEO Sells Shares
Amit Gupta, Chief Executive Officer and a Director of Cardlytics, Inc., sold 13,461 shares of common stock on August 16, 2026.
NASDAQ
Form 4: Yukon New Parent CFO Buys Shares
Brandon Satoren, Chief Financial Officer of Yukon New Parent, Inc., purchased 2,000 shares of common stock on August 17, 2026.
NYSE
Michael P Gianoni, a Director of Teradata Corp /De/, received 2,197 shares of common stock on August 14, 2026.
NASDAQ
Rhonda M. Chicko, Chief Financial Officer of Cyclerion Therapeutics, Inc., reported multiple transactions in common stock on August 14, 2026.
NASDAQ
Richard Bennett Wimmer, a Director of Cardinal Infrastructure Group Inc., purchased 7,500 shares of common stock on August 17, 2026 for $39.13 per share.